Drugs from Apotex Research Private Ltd., of Bangalore, are once again on import alert following an FDA inspection, and the company was slapped with another warning letter. The latest letter cited the company for inadequate quality systems and a quality unit that doesn't fully exercise authority, such as ensuring that appropriate investigations are performed with sound conclusions, identifying root causes and supporting scientific justification.